
Mass infection prevention and mass vaccination with leaky Covid-19 vaccines in the midst of the pandemic can only breed highly infectious variants.
| Platform | Pricing | Freemium | Publishes | Daily | |
|---|---|---|---|---|---|
| Issues | 297 | Subscribers | Read | voiceforscienceandsolidarity.substa... |
Curious about how many subscribers Voice for Science and Solidarity by Geert Vanden Bossche has or want to find similar newsletters? Reletter has got you covered. We collated all the information we could find from across the web in our database of over three million newsletters.
Check the email archives, get traffic estimates, engagement scores and more to discover the best advertising opportunities.
Our search tool helps you locate relevant newsletters for any topic and compare their stats for better sponsorship decisions.
How this newsletter ranks in the official Substack charts.
| #32 | |
| #31 |
Recent posts by this newsletter. Browse the email archive.
This is an interesting but, in my view, alarming development; where initially everything progressed slowly, it now takes less and less time for newly emerging Omicron clades to dominate in prevalence… In my view, it is only a matter of time...
This is yet another publication on mucosal Covid-19 vaccines that recently made the rounds across social media: https://pubmed.ncbi.nlm.nih.gov/40859051/
Once again, our scientists, experts and public health officials have no clue how this pandemic is going to end - some even think it will never end and conveniently refer to an ‘endemic’ state.
Some followers were wondering what I meant in my previous Substack article (https://voiceforscienceandsolidarity.substack.com/p/this-in-a-nutshell-is-how-the-ongoing) by:
The writers behind this newsletter.
PhD, DVM Independent Vaccine Research Consultant Vaccine Discovery & Preclinical Research.
You can find recent issues that have been published by this newsletter on Reletter by scrolling up to where it says Latest Issues. Tap on the link for any of the most recent emails or hit More Issues to see older ones.
To see how many people subscribe to this newsletter, simply upgrade your Reletter account. We provide readership numbers and lots of other stats for this newsletter so you can decide if it's worth reaching out to.
Newsletter advertising can be extremely effective when it's done right. Before you pitch this newsletter as a potential sponsor or partner, make sure that you've done your research and checked its newsletter stats with Reletter.
Then, personalize one of our winning pitching templates and send it to the right person using the contact info provided.
Newsletter ad rates (or CPM) vary depending on many factors, including industry, number of subscribers, open rate, ad placement and more.
To find out how much an ad will cost, contact this newsletter using the contact information provided and ask for a copy of their media kit.
Scroll up to where it says Similar Newsletters to see other publications like this newsletter. You can also search our email newsletter directory to discover other newsletters that cover the topics you're interested in.
Reletter provides this newsletter's website URL above, where you will often find their contact information. We also provide links to associated social media accounts and pitching templates so you can reach out fast.